Management of primary liver sarcomas

Area of Science:

• Hepatobiliary oncology
• Sarcoma research
• Surgical oncology

Background:

• Primary hepatic sarcoma is a rare liver malignancy.
• Limited data exists on treatment and prognostic factors for this condition.

Purpose of the Study:

• To define treatment strategies and long-term outcomes for primary hepatic sarcoma.
• To identify key prognostic factors influencing patient survival.

Main Methods:

• Retrospective analysis of 35 patients (30 primary hepatic sarcoma, 5 primary carcinosarcoma) treated between 1981 and 2004.
• Evaluation of patient demographics, tumor characteristics, treatment modalities, and actuarial survival rates.

Main Results:

• Complete tumor resection (R0) correlated with improved survival; 11 patients achieving R0 had a 64% 5-year disease-specific survival.
• Tumor histology significantly impacted prognosis: high-grade sarcomas had poorer outcomes, while embryonal sarcomas showed 80% 5-year survival post-R0 resection.
• Epithelioid hemangioendothelioma patients managed non-surgically had a 67% 5-year survival; patients without R0 resection had no 3-year survivors.
• Primary carcinosarcoma of the liver demonstrated a poor prognosis with limited survival.

Conclusions:

• Tumor histology and the achievement of complete surgical resection are critical determinants of outcome in primary hepatic sarcoma.
• Development of novel systemic therapies is essential to improve survival rates for patients with advanced or unresectable liver sarcomas.